tm logo
SHIELDTX
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 09 Jul 2024

Last Applicant/ Owned by

Suite 200

San Diego

CA

92121

Serial Number

98240129 filed on 25th Oct 2023

Registration Number

N/A

Correspondent Address

Daniel Chalker

Daniel Chalker CHALKER FLORES, LLP

DALLAS, TX 75254

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SHIELDTX

Medical scientific research testing, research and development services in the fields of immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical scientific research testing, research and development services in the fields of immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98240129

Mark Type

No Service Mark

Attorney Docket Number

No IBIO:3012

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
10th Dec 2024TEAS STATEMENT OF USE RECEIVED
09th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th May 2024PUBLISHED FOR OPPOSITION
24th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
25th Mar 2024ASSIGNED TO EXAMINER
31st Oct 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28th Oct 2023NEW APPLICATION ENTERED